Download PDF
Thromb Haemost 1966; 16(01/02): 061-068
DOI: 10.1055/s-0038-1655627
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

A Comparative Study of the Solvents Commonly Used to Detect Fibrin Stabilisation

H. M Tyler
1   Department of Pathology, Institute of Orthopaedics, (University of London), Brockley Hill, Stanmore, Middlesex
› Author Affiliations
Further Information

Publication History

Publication Date:
26 June 2018 (online)

    Permissions and Reprints

Summary

The actions of 2% acetic acid, 1% monochloracetic acid and 8 M urea have been studied on fibrin of the “soluble” and “insoluble” types. The two acidic reagents have a much more rapid solubilising action than does 8 M urea, and are also more efficient in solubilising “partially stabilised” fibrin.

Provided sufficient time is allowed for a fibrin or whole-blood clot to form, it seems unlikely that qualitative differences in the solubilising action of the three solvents will be found.

For a clinical assessment of the stabilisation of blood-clot, examination can be made after 1 hr incubation of the clot in either of the acidic solvents. There is no apparent advantage in the commonly used prolonged incubations in 5 or 8 M urea.

 

  • References

  • 1 Laki K, Lorand L. On solubility of fibrin clots. Science 108: 280 1948;
    CrossrefPubMedGoogle Scholar
  • 2 Loewy A. G, Dunathan K, Kriel R, Wolfinger H. L. Fibrinase I. Purification of substrate and enzyme. J. biol. Chem 236: 2625 1961;
    PubMedGoogle Scholar
  • 3 Lorand L. Properties and significance of the fibrin stabilising factor (FSF). Thrombos. Diathes. haemorrh. (Stuttg.) 7 (Suppl. 01) 238 1962;
    PubMedGoogle Scholar
  • 4 Laki K, Gladner J. A. Chemistry and physiology of the fibrinogen-fibrin transition. Physiol. Rev 44: 127 1964;
    CrossrefPubMedGoogle Scholar
  • 5 Duckert F, Jung E, Shmerling D.H. Hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilising factor deficiency. Thrombos. Diathes. haemorrh. (Stuttg.) 5: 179 1960;
    PubMedGoogle Scholar
  • 6 Ikkala E, Nevanlinna H. R. Congenital deficiency of fibrin stabilising factor. Thrombos. Diathes. haemorrh. (Stuttg.) 7: 567 1962;
    PubMedGoogle Scholar
  • 7 Josso F, Prou-Wartelle Odette, Abagille D, Soulier J. P. Le deficit congenital en facteur stabilisant de la fibrine (facteur XIII): etude de deux cas. Nouv. Rev. franc. Hémat 4: 267 1964;
    PubMedGoogle Scholar
  • 8 Losowski M. S, Hall R, Goldie W. Congenital deficiency of fibrin-stabilising factor. Lancet II: 156 1965;
    PubMedGoogle Scholar
  • 9 Norman P. S. Inhibition of plasmin by serum or plasma. J. exp. Med 108: 53 1958;
    CrossrefPubMedGoogle Scholar
  • 10 Tyler H. M, Lack G. H. A tissue fibrin-stabilising factor and fibrinolytic inhibition. Nature (Lond.) 202: 1114 1964;
    CrossrefPubMedGoogle Scholar
  • 11 Tyler H. M, Lack G. H. Studies on the relationship between fibrin-stabilising factor, calcium and inhibition of fibrinolysis. Clin. Sci 28: 527 1965;
    PubMedGoogle Scholar
  • 12 Katz S, Shulman S, Tinoco I, Billick I. H, Gutfreund K, Ferry J. D. The conversion of fibrinogen to fibrin XIV. The effect of Ca++ on the formation and dissociation of intermediate polymers. Arch. Biochem 47: 165 1953;
    CrossrefPubMedGoogle Scholar
  • 13 Rosenfeld G, Januszky B. The accelerating effect of calcium on the fibrinogen to fibrin transformation. Science 116: 36 1952;
    CrossrefPubMedGoogle Scholar
  • 14 Loewy A. G, Gallant J. A, Dunathan K. Fibrinase. IV. Effect on fibrin solubility. J. biol. Chem 236: 2648 1961;
    PubMedGoogle Scholar
  • 15 Endres G. F, Ehrenpreis S, Scheraga H. A. Covalent bonding in the reversible polymerisation of fibrin monomer. Biochim. biophys. Acta (Amst.) 104: 620 1965;
    CrossrefPubMedGoogle Scholar
  • 16 Lorand L, Jacobsen A. Specific inhibitors and the chemistry of fibrin polymerisation. Biochemistry 3: 1939 1964;
    CrossrefPubMedGoogle Scholar